{name}
{subtitle}
Study of Pembrolizumab (MK-3475) in Combination With Adjuvant Chemotherapy With or Without Radiotherapy in Participants With Newly Diagnosed Endometrial Cancer After Surgery With Curative Intent (MK-3475-B21 / KEYNOTE-B21 / ENGOT-en11 / GOG-3053)
city
~21 mi. (Nantes, France, +176 more cities)
facility
Hopital prive du Confluent ( Site 2061)
condition
Endometrial Carcinoma, +1 more condition
drug
chemotherapy, +2 more drugs
drug type
chemotherapy, +2 more types
Perioperative Pembrolizumab (MK-3475) Plus Cystectomy or Perioperative Pembrolizumab Plus Enfortumab Vedotin Plus Cystectomy Versus Cystectomy Alone in Cisplatin-ineligible Participants With Muscle-invasive Bladder Cancer (MK-3475-905/KEYNOTE-905/EV-303)
city
~21 mi. (Nantes, France, +163 more cities)
facility
CHU Hotel Dieu Nantes ( Site 0458)
drug
cystectomy, +2 more drugs
drug type
chemotherapy, +3 more types
Study Of Venetoclax Tablet With Intravenous or Subcutaneous Azacitidine to Assess Change in Disease Activity In Adult Participants With Newly Diagnosed Higher-Risk Myelodysplastic Syndrome
city
~21 mi. (Nantes, France, +201 more cities)
facility
CHU de Nantes, Hotel Dieu -HME /ID# 222074
drug
azacitidine, +1 more drug
A Study Evaluating Safety and Efficacy of Venetoclax in Combination With Azacitidine Versus Standard of Care After Allogeneic Stem Cell Transplantation (SCT) in Participants With Acute Myeloid Leukemia (AML)
city
~21 mi. (Nantes, France, +127 more cities)
facility
CHU de Nantes, Hotel Dieu -HME /ID# 214060
drug
azacitidine, +2 more drugs
A Study of Oral Venetoclax Tablets and Oral Azacitidine Versus Oral Azacitidine as Maintenance Therapy in Adult Participants With Acute Myeloid Leukemia in First Remission After Conventional Chemotherapy
city
~21 mi. (Nantes, France, +197 more cities)
facility
CHU de Nantes, Hotel Dieu -HME /ID# 217367
biomarker
BCR-ABL1 Fusion, +47 more biomarkers
drug
azacitidine, +1 more drug
A Study Comparing Imetelstat Versus Best Available Therapy for the Treatment of Intermediate-2 or High-risk Myelofibrosis (MF) Who Have Not Responded to Janus Kinase (JAK)-Inhibitor Treatment
city
~21 mi. (Nantes, France, +142 more cities)
facility
CHU De Nantes - Hématologie C
biomarker
del(11)(q10), +27 more biomarkers
drug
imetelstat, +1 more drug
A Study of Venetoclax and Dexamethasone Compared With Pomalidomide and Dexamethasone in Participants With Relapsed or Refractory Multiple Myeloma
city
~21 mi. (Nantes, France, +156 more cities)
facility
CHU de Nantes, Hotel Dieu -HME /ID# 200099
biomarker
IGH-CCND1 Fusion, +1 more biomarker
drug
dexamethasone, +1 more drug
drug type
chemotherapy, +1 more type